Royal Bank of Canada’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.64M Buy
391,754
+389,045
+14,361% +$3.61M ﹤0.01% 2586
2025
Q1
$20K Sell
2,709
-3,331
-55% -$24.6K ﹤0.01% 5546
2024
Q4
$51K Sell
6,040
-12,681
-68% -$107K ﹤0.01% 5197
2024
Q3
$163K Buy
18,721
+1,554
+9% +$13.5K ﹤0.01% 4548
2024
Q2
$117K Buy
17,167
+14,578
+563% +$99.4K ﹤0.01% 4788
2024
Q1
$24K Sell
2,589
-21,503
-89% -$199K ﹤0.01% 5401
2023
Q4
$107K Sell
24,092
-145,680
-86% -$647K ﹤0.01% 5053
2023
Q3
$534K Buy
169,772
+4,717
+3% +$14.8K ﹤0.01% 3526
2023
Q2
$852K Sell
165,055
-19,257
-10% -$99.4K ﹤0.01% 3133
2023
Q1
$971K Buy
184,312
+174,942
+1,867% +$922K ﹤0.01% 3039
2022
Q4
$26K Buy
9,370
+4,132
+79% +$11.5K ﹤0.01% 5723
2022
Q3
$22K Buy
5,238
+4,304
+461% +$18.1K ﹤0.01% 5612
2022
Q2
$4K Sell
934
-67,609
-99% -$290K ﹤0.01% 6273
2022
Q1
$339K Sell
68,543
-20,628
-23% -$102K ﹤0.01% 4153
2021
Q4
$622K Buy
89,171
+7,894
+10% +$55.1K ﹤0.01% 3792
2021
Q3
$812K Buy
81,277
+3,282
+4% +$32.8K ﹤0.01% 3450
2021
Q2
$1.11M Sell
77,995
-1,707
-2% -$24.2K ﹤0.01% 3178
2021
Q1
$1.31M Sell
79,702
-6,080
-7% -$99.9K ﹤0.01% 2948
2020
Q4
$1.78M Sell
85,782
-7,012
-8% -$145K ﹤0.01% 2609
2020
Q3
$706K Sell
92,794
-29,752
-24% -$226K ﹤0.01% 3137
2020
Q2
$1.02M Sell
122,546
-7,976
-6% -$66.5K ﹤0.01% 2768
2020
Q1
$646K Sell
130,522
-22,958
-15% -$114K ﹤0.01% 2981
2019
Q4
$606K Sell
153,480
-1,801
-1% -$7.11K ﹤0.01% 3298
2019
Q3
$472K Buy
155,281
+7,803
+5% +$23.7K ﹤0.01% 3343
2019
Q2
$648K Buy
147,478
+39,218
+36% +$172K ﹤0.01% 3170
2019
Q1
$430K Sell
108,260
-16,375
-13% -$65K ﹤0.01% 3322
2018
Q4
$496K Buy
124,635
+22,985
+23% +$91.5K ﹤0.01% 3140
2018
Q3
$700K Buy
101,650
+16,077
+19% +$111K ﹤0.01% 3121
2018
Q2
$578K Buy
85,573
+3,699
+5% +$25K ﹤0.01% 3150
2018
Q1
$533K Sell
81,874
-1,509
-2% -$9.82K ﹤0.01% 3102
2017
Q4
$371K Sell
83,383
-80,678
-49% -$359K ﹤0.01% 3328
2017
Q3
$1.01M Sell
164,061
-39,497
-19% -$244K ﹤0.01% 2626
2017
Q2
$1.89M Buy
203,558
+5,853
+3% +$54.3K ﹤0.01% 2138
2017
Q1
$1.84M Buy
197,705
+24,331
+14% +$226K ﹤0.01% 2156
2016
Q4
$1.45M Buy
173,374
+77,959
+82% +$652K ﹤0.01% 2268
2016
Q3
$655K Buy
95,415
+46,205
+94% +$317K ﹤0.01% 2838
2016
Q2
$244K Buy
49,210
+46,200
+1,535% +$229K ﹤0.01% 3609
2016
Q1
$29K Buy
3,010
+243
+9% +$2.34K ﹤0.01% 4666
2015
Q4
$26K Sell
2,767
-662
-19% -$6.22K ﹤0.01% 4853
2015
Q3
$48K Buy
3,429
+1,528
+80% +$21.4K ﹤0.01% 4567
2015
Q2
$40K Buy
1,901
+1,470
+341% +$30.9K ﹤0.01% 4865
2015
Q1
$18K Sell
431
-308
-42% -$12.9K ﹤0.01% 4939
2014
Q4
$17K Sell
739
-2,911
-80% -$67K ﹤0.01% 4872
2014
Q3
$55K Buy
+3,650
New +$55K ﹤0.01% 4355